M Baulac, J P Nordmann, Y Lanoé. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Anticonvulsants/adverse effectsEpilepsies, Myoclonic/drug therapyEpilepsy, Tonic-Clonic/drug therapyFemaleFollow-Up StudiesGABA Agonists/adverse effectsGABA Modulators/adverse effectsHumansMiddle AgedPhenobarbital/adverse effectsVision Disorders/chemically inducedVisual Fields/drug effectsgamma-Aminobutyric Acid/adverse effectsgamma-Aminobutyric Acid/analogs & derivatives
Substances: See more » AnticonvulsantsGABA AgonistsGABA Modulatorsprogabidegamma-Aminobutyric AcidPhenobarbital
Year: 1998 PMID: 9716066 DOI: 10.1016/S0140-6736(05)79254-0
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321